Bavituximab
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Bavituximab, covering 2008-05-07 to 2025-02-28. Get the full timeline:
Most recent: Clinical Trial Update: 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck [Phase 2]